NCT01720563 2025-06-04
A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy
PhytoHealth Corporation
Phase 2 Terminated
PhytoHealth Corporation
Brown University
Dana-Farber Cancer Institute
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
Hellenic Oncology Research Group
Groupe Oncologie Radiotherapie Tete et Cou